Correlation Between Theseus Pharmaceuticals and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Theseus Pharmaceuticals and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Theseus Pharmaceuticals and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Theseus Pharmaceuticals and Crispr Therapeutics AG, you can compare the effects of market volatilities on Theseus Pharmaceuticals and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Theseus Pharmaceuticals with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Theseus Pharmaceuticals and Crispr Therapeutics.
Diversification Opportunities for Theseus Pharmaceuticals and Crispr Therapeutics
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Theseus and Crispr is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Theseus Pharmaceuticals and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Theseus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Theseus Pharmaceuticals are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Theseus Pharmaceuticals i.e., Theseus Pharmaceuticals and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Theseus Pharmaceuticals and Crispr Therapeutics
Given the investment horizon of 90 days Theseus Pharmaceuticals is expected to generate 2.51 times more return on investment than Crispr Therapeutics. However, Theseus Pharmaceuticals is 2.51 times more volatile than Crispr Therapeutics AG. It trades about 0.03 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.02 per unit of risk. If you would invest 566.00 in Theseus Pharmaceuticals on August 30, 2024 and sell it today you would lose (195.00) from holding Theseus Pharmaceuticals or give up 34.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 31.25% |
| Values | Daily Returns |
Theseus Pharmaceuticals vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Theseus Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Crispr Therapeutics |
Theseus Pharmaceuticals and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Theseus Pharmaceuticals and Crispr Therapeutics
The main advantage of trading using opposite Theseus Pharmaceuticals and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Theseus Pharmaceuticals position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Theseus Pharmaceuticals vs. Relay Therapeutics | Theseus Pharmaceuticals vs. Century Therapeutics | Theseus Pharmaceuticals vs. Blueprint Medicines Corp | Theseus Pharmaceuticals vs. Pmv Pharmaceuticals |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |